DEXAMETHASONE PO4 / MOXIFLOXACIN HCL 0.1% / 0.5% (SINGLE USE) OMNI BY OSRX trademarks | Applied Marks - Trademark, Domain Name and Social Media Protection for Brands - /\\\ Applied Marks

exact DEXAMETHASONE PO4 / MOXIFLOXACIN HCL 0.1% / 0.5% (SINGLE USE) OMNI BY OSRX exact DEXAMETHASONE PO4 / MOXIFLOXACIN HCL 0.1% / 0.5% (SINGLE USE) OMNI BY OSRX

Trademarks matching 'dexamethasone po4 / moxifloxacin hcl 0.1% / 0.5% (single use) omni by osrx'

Summary of page content
2019-05-09
US
Trademark Image
The mark consists of the words "DEXAMETHASONE PO4 / MOXIFLOXACIN HCl 0.1% / 0.5% (SINGLE USE)" above the words of "OMNI BY OSRX". The "DEXAMETHASONE PO4 / MOXIFLOXACIN HCl" words are above the "0.1% / 0.5% (SINGLE USE)" language. The "0.1% / 0.5%" language is above the "(SINGLE USE)" language. The word "OMNI" is above the words "BY OSRX". The lettering for "OMNI" is larger than the lettering for "BY OSRX". There is a shaded circle behind most of the letter "M" in "OMNI". There is a top arc that begins between the "O" and the "M" of "OMNI" and arcs towards the right ending to the right of the "I" in "OMNI" and ending to the right of the "X" in "OSRX". There is a bottom arc that begins at the "N" in "OMNI" and then arcs towards the left ending to the left of the "O" in "OMNI".
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    ophthalmic preparations containing dexamethasone po4and moxifloxacin hcl
819
SU - REGISTRATION REVIEW COMPLETE
2021-04-06
2021-04-07
group health care technologies intl cd usp extended release capsules mg tablets advantage corporation handcrafted leathergoods holiday cruise lines hotel
First 1 Last  1 of 1
NEED HELP? Chat with us online

Copyright 2008 - 2024 Applied Marks Pty Ltd (ACN 134 698 249). All rights reserved. Terms of Service, Privacy Policy and Acceptable Use Policy.